Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-gray breast radiotherapy for invasive breast cancer

Annals of the Royal College of Surgeons of England

Volumn 92, Issue 7, 2010, Pages 562-568

  Liau, Siong Seng ^a   Cariati, Massimiliano ^a   Noble, David ^a   Wilson, Charles ^a   Wishart, Gordon C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Breast conserving surgery; Ipsilateral breast tumour recurrence; Radiotherapy

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; EPIDEMIOLOGY; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SEGMENTAL MASTECTOMY; STANDARD; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 77958178176     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588410X12699663903476     Document Type: Article

References (26)

1. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992; 84: 683-9.
2. Calle R, Vilcoq JR, Zafrani B, Vielh P, Fourquet A. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys 1986; 12: 873-8.
3. Fredriksson I, Liljegren G, Palm-Sjovall M, Arnesson LG, Emdin SO, Fornander T et al. Risk factors for local recurrence after breast-conserving surgery. Br J Surg 2003; 90: 1093-102.
4. Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004; 100: 1823-32.
5. Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM et al. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer 2005; 104: 20-9.
6. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 1990; 65: 1867-78.
7. Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary SE et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002; 9: 256-65.
8. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000; 18: 2817-27.
9. Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR et al. Longterm follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence. Int J Radiat Oncol Biol Phys 1997; 38: 541-50.
10. Elkhuizen PH, van Slooten HJ, Clahsen PC, Hermans J, van de Velde CJ, van den Broek LC et al. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol 2000; 18: 1075-83.
11. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Bartelink H. Risk factors in breast-conservation therapy. J Clin Oncol 1994; 12: 653-60.
12. Association of Breast Surgery. Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol 2005; 31 (Suppl 1): 1-21.
13. Macmillan RD, Purushotham AD, Mallon E, Love JG, George WD. Tumour bed positivity predicts outcome after breast-conserving surgery. Br J Surg 1997; 84: 1559-62.
14. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008; 371: 1098-107.
15. Blamey RW, Ellis IO, Pinder SE, Lee AH, Macmillan RD, Morgan DA et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer 2007; 43: 1548-55.
16. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002; 184: 383-93.
17. Horiguchi J, Iino Y, Takei H, Maemura M, Yokoe T, Niibe H et al. Surgical margin and breast recurrence after breast-conserving therapy. Oncol Rep 1999; 6: 135-8.
18. Schmidt-Ullrich R, Wazer DE, Tercilla O, Safaii H, Marchant DJ, Smith TJ et al. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys 1989; 17: 733-8.
19. Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994; 74: 1746-51.
20. Dewar JA, Haviland JS, Agrawal RK, Bliss JM, Hopwood P, Magee B et al on behalf of the START Trials centres. Hypofractionation for early breast cancer: First results of the UK standardisation of breast radiotherapy (START) trials. 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25 (Suppl): LBA518.
21. Miller DV, Leontovich AA, Lingle WL, Suman VJ, Mertens ML, Lillie J et al. Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas. Mod Pathol 2004; 17: 756-64.
22. Hanna WM, Kahn HJ, Chapman JA, Fish EB, Lickley HL, McCready DR. Pathologic characteristics of breast cancer that predict for local recurrence after lumpectomy alone. Breast J 1999; 5: 105-11.
23. Locker AP, Ellis IO, Morgan DA, Elston CW, Mitchell A, Blamey RW. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 1989; 76: 890-4.
24. Mansell J, Monypenny IJ, Skene AI, Abram P, Carpenter R, Gattuso JM et al. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat 2009; 117: 91-8.
25. Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol 2007; 20: 183-91.
26. Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 2006; 8: R62.